| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974846 | The Journal of Heart and Lung Transplantation | 2005 | 9 Pages |
Abstract
Nebulized NAC administered before or shortly after death attenuates early ischemia reperfusion injury via upregulation of glutathione. NAC might be a promising tool to protect the pulmonary graft from both controlled and uncontrolled NHBD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Filip R. MD, Wim A. MD, PhD, Bart M. Vanaudenaerde, Nicole C. Jannis, Arne P. MD, Geert M. MD, PhD, Toni E. MD, PhD, Dirk E.M. MD, PhD,